Answers are grounded in this paper and cite their sources.
Background/Objectives: Dry eye disease (DED) disrupts corneal epithelial homeostasis and may cause progressive ocular surface injury. Although MSC-derived exosomes have shown therapeutic efficacy after the establishment of DED, their prophylactic potential remains unclear. This study evaluated whether topical UCMSC-derived exosome preconditioning protects the cornea against subsequent aqueous-deficient DED. Methods: Forty female Sprague-Dawley rats aged six to eight weeks were allocated to the prophylactic exosome treatment (PTE) or untreated control groups. PTE rats received low-concentration UCMSC-derived exosome eye drops once daily for 14 days before unilateral lacrimal gland excision; treatment ceased immediately after surgery. Clinical, AS-OCT, histological, ZO-1, Ki-67, and TUNEL assessments were conducted before induction and through Day 14. Corneal TNF-α, IL-1β, TGF-β, and IL-10 expression was measured via qPCR at Day 0. Results: PTE reduced overall corneal neovascularization (mean vessel length, 46.91 vs. 117.06 µm; p = 0.015) and epithelial thickening (54.01 vs. 71.80 µm; p = 0.006). ZO-1 immunoreactivity was significantly greater in the PTE group (D14: 0.678 vs. 0.154; p < 0.001), while there were significantly fewer TUNEL-positive cells at D0 (17.5 vs. 59.5; p < 0.001) and D7 (16.25 vs. 57.25; p < 0.001). Fluorescein staining, stromal thickness, Ki-67 immunoreactivity, and cytokine transcription did not differ significantly between groups. Conclusions: Preconditioning with topical UCMSC-derived exosomes conferred selective corneal protection after dosing ended, characterized by reduced angiogenesis and apoptosis and better preservation of epithelial thickness and tight-junction integrity. These findings support prophylactic exosome exposure as a proof-of-concept strategy for enhancing corneal resilience before predictable ocular surface injury in this severe experimental model; however, the absence of a vehicle-treated control and limited mechanistic characterization warrant further investigation before clinical translation.
No takes yet. Share an insight, caveat, or question.
Chan et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: